Literature DB >> 34167488

Next-generation sequencing combined with serological tests based pathogen analysis for a neurocysticercosis patient with a 20-year history:a case report.

Bin Chen1, Zheng Chen1, Yi-Shu Yang1, Gui-Lan Cai1, Xiao-Jiao Xu1, Hong-Zhi Guan2, Hai-Tao Ren2, Hou-Zhen Tuo3.   

Abstract

BACKGROUND: Neurocysticercosis (NCC) is the most common helminthic infection of the central nervous system (CNS) caused by the larval stage of Taenia solium. Accurate and early diagnosis of NCC remains challenging due to its heterogeneous clinical manifestations, neuroimaging deficits, variable sensitivity, and specificity of serological tests. Next-generation sequencing (NGS)-based pathogen analysis in patient's cerebrospinal fluid (CSF) with NCC infection has recently been reported indicating its diagnostic efficacy. In this case study, we report the diagnosis of a NCC patient with a symptomatic history of over 20 years using NGS analysis and further confirmation of the pathology by immunological tests. CASE
PRESENTATION: This study reports the clinical imaging and immunological features of a patient with a recurrent headache for more than 20 years, which worsened gradually with the symptom of fever for more than 7 years and paroxysmal amaurosis for more than 1 year. By utilizing NGS technique, the pathogen was detected in patient's CSF, and the presence of Taenia solium-DNA was confirmed by a positive immunological reaction to cysticercus IgG antibody in CSF and serum samples. The symptoms of the patient were alleviated, and the CSF condition was improved substantially after the anti-helminthic treatment.
CONCLUSIONS: This study suggests that combining CSF NGS with cysticercus IgG testing may be a highly promising approach for diagnosing the challenging cases of NCC. Further studies are needed to evaluate the parasitic DNA load in patients' CSF for the diagnosis of disease severity, stage, and monitoring of therapeutic responses.

Entities:  

Keywords:  Amaurosis; Case report; Cysticercus IgG; Headache; Long history; Neurocysticercosis; Next-generation sequencing; Taenia solium

Year:  2021        PMID: 34167488     DOI: 10.1186/s12883-021-02277-7

Source DB:  PubMed          Journal:  BMC Neurol        ISSN: 1471-2377            Impact factor:   2.474


  20 in total

Review 1.  Clinical symptoms, diagnosis, and treatment of neurocysticercosis.

Authors:  Hector H Garcia; Theodore E Nash; Oscar H Del Brutto
Journal:  Lancet Neurol       Date:  2014-11-10       Impact factor: 44.182

2.  Next-generation sequencing of the cerebrospinal fluid in the diagnosis of neurobrucellosis.

Authors:  Siyuan Fan; Haitao Ren; Yanping Wei; Chenhui Mao; Zhenzi Ma; Lu Zhang; Li Wang; Ying Ge; Taisheng Li; Liying Cui; Honglong Wu; Hongzhi Guan
Journal:  Int J Infect Dis       Date:  2017-11-28       Impact factor: 3.623

3.  Relevance of 3D magnetic resonance imaging sequences in diagnosing basal subarachnoid neurocysticercosis.

Authors:  Roger Carrillo Mezo; Javier Lara García; Mariana Arroyo; Agnès Fleury
Journal:  Acta Trop       Date:  2015-08-29       Impact factor: 3.112

4.  Actionable diagnosis of neuroleptospirosis by next-generation sequencing.

Authors:  Michael R Wilson; Samia N Naccache; Erik Samayoa; Mark Biagtan; Hiba Bashir; Guixia Yu; Shahriar M Salamat; Sneha Somasekar; Scot Federman; Steve Miller; Robert Sokolic; Elizabeth Garabedian; Fabio Candotti; Rebecca H Buckley; Kurt D Reed; Teresa L Meyer; Christine M Seroogy; Renee Galloway; Sheryl L Henderson; James E Gern; Joseph L DeRisi; Charles Y Chiu
Journal:  N Engl J Med       Date:  2014-06-04       Impact factor: 91.245

5.  Next-generation sequencing of cerebrospinal fluid for the diagnosis of neurocysticercosis.

Authors:  Xiaofei Fei; Chaoyang Li; Yun Zhang; Hongya Zhang; Xuewu Liu; Xinchao Ji; Yajun Shi; Na Liu; Mengli Wu; Fang Du; Yining Yang; Wen Dai; TingTing Liu; Ying He; Ting Bian; Huimin Zhou; Xingyue An; Zheng Cai; Jian Shi; Guodong Feng; Ming Shi; Gang Zhao
Journal:  Clin Neurol Neurosurg       Date:  2020-02-26       Impact factor: 1.876

6.  ParticleCall: a particle filter for base calling in next-generation sequencing systems.

Authors:  Xiaohu Shen; Haris Vikalo
Journal:  BMC Bioinformatics       Date:  2012-07-09       Impact factor: 3.169

7.  New diagnostic criteria for neurocysticercosis: Reliability and validity.

Authors:  Arturo Carpio; Agnès Fleury; Matthew L Romo; Ronaldo Abraham; Jaime Fandiño; Juan C Durán; Graciela Cárdenas; Jorge Moncayo; Cleonísio Leite Rodrigues; Daniel San-Juan; Marcos Serrano-Dueñas; Oswaldo Takayanagui; Josemir W Sander
Journal:  Ann Neurol       Date:  2016-08-13       Impact factor: 10.422

8.  Next generation sequencing based pathogen analysis in a patient with neurocysticercosis: a case report.

Authors:  Ping Liu; Xing Weng; Jiajia Zhou; Xiaolin Xu; Fangping He; Yue Du; Honglong Wu; Yanping Gong; Guoping Peng
Journal:  BMC Infect Dis       Date:  2018-03-06       Impact factor: 3.090

9.  Validity of a PCR assay in CSF for the diagnosis of neurocysticercosis.

Authors:  Arturo Carpio; Alfredo Campoverde; Matthew L Romo; Lorena García; Luis M Piedra; Mónica Pacurucu; Nelson López; Jenner Aguilar; Sebastian López; Luis C Vintimilla; Ana M Toral; Pablo Peña-Tapia
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-01-16

10.  Next-Generation Sequencing of Cerebrospinal Fluid for the Diagnosis of Neurocysticercosis.

Authors:  Siyuan Fan; Xiaodong Qiao; Lei Liu; Honglong Wu; Jiali Zhou; Ruixue Sun; Qing Chen; Yan Huang; Chenhui Mao; Jing Yuan; Qiang Lu; Ying Ge; Yongjun Li; Haitao Ren; Jiawei Wang; Liying Cui; Weili Zhao; Hongzhi Guan
Journal:  Front Neurol       Date:  2018-06-19       Impact factor: 4.003

View more
  1 in total

1.  Diagnostic value of metagenomic next-generation sequencing of bronchoalveolar lavage fluid for the diagnosis of suspected pneumonia in immunocompromised patients.

Authors:  Pengcheng Lin; Yi Chen; Shanshan Su; Wengang Nan; Lingping Zhou; Ying Zhou; Yuping Li
Journal:  BMC Infect Dis       Date:  2022-04-29       Impact factor: 3.667

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.